All tenders
BidClosedVerified details

GEM/2026/B/7897265

Emicizumab inj. 30mg 1.0ml A,Emicizumab inj. 30mg 1.0ml B,Emicizumab inj. 30mg 1.0ml C,Emicizumab i

Published

10 Aug 2026, 12:10 pm

Closes

01 Sept 2026, 09:00 am

Pre-bid meet

Bid opening

01 Sept 2026, 09:30 am

Financial details

Estimated value
EMD amount
ePBG %
Advisory bank
Evaluation methodItem wise evaluation
Bid validity180 days

Buyer details

MinistryMinistry of Health and Family Welfare
DepartmentDepartment of Health Research
OrganisationIndian Council Of Medical Research (icmr)
OfficeMumbai

BoQ items (5)

#ItemDescriptionQtyUnit
Schedule 1Emicizumab Inj. 30mg 1.0ml A3
Schedule 2Emicizumab Inj. 30mg 1.0ml B3
Schedule 3Emicizumab Inj. 30mg 1.0ml C3
Schedule 4Emicizumab Inj. 30mg 1.0ml D3
Schedule 5Emicizumab Inj. 30mg 1.0ml E3

Consignees (5)

#ConsigneeAddressQtyDelivery (days)
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai390
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai390
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai390
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai390
1Meenakshi Ulhas Kesarkar400012,ICMR-National Institute of Immunohaematology, 13th Floor, New Multistore Bldg, K.E.M Hospital Campus, Parel, Mumbai390

Exemptions & flags

MSE exemption
Startup exemption
OEM required

Quick facts

Bid ID9732860
Quantity15
Status1
Details fetched11 Aug 2026, 10:07 am

Contact us about this tender

Need help bidding on this tender? Send us your details and our team will reach out.